drugset
drugset / Trial / NCT07145814

Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery

NCT07145814 ↗

Completed 60 enrolled People's Hospital of Guangxi Zhuang Autonomous Region
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This randomized controlled trial evaluated the dose-dependent effects of dexmedetomidine (DEX) on pulmonary function and aquaporin-1 (AQP1) expression during one-lung ventilation (OLV) in thoracoscopic surgery.

Timeline

Start
2018-01-05
Primary completion
2019-03-29
Completion
2019-03-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg —
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —

Indications

acute lung injury